MED - Medifast, Inc.

NYSE - Nasdaq Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,598,577
1,598,577
1,526,087
934,842
713,672
Cost of revenue
458,163
458,163
398,490
237,027
176,814
Gross profit
1,140,414
1,140,414
1,127,597
697,815
536,858
Operating expenses
Selling general and administrative
955,608
955,608
911,356
563,656
445,819
Total operating expenses
955,608
955,608
911,356
563,656
445,819
Operating income or loss
184,806
184,806
216,241
134,159
91,039
Total other income/expenses net
-46
-46
119
-140
29
Income before tax
184,059
184,059
216,129
134,265
92,363
Income tax expense
40,491
40,491
52,098
31,406
14,447
Income from continuing operations
143,568
143,568
164,031
102,859
77,916
Net income
143,568
143,568
164,031
102,859
77,916
Net income available to common shareholders
143,568
143,568
164,031
102,859
77,916
Basic EPS
-
-
14.01
8.74
6.62
Diluted EPS
-
-
13.89
8.68
6.43
Basic average shares
-
-
11,705
11,771
11,771
Diluted average shares
-
-
11,813
11,850
12,117
EBITDA
-
195,786
223,053
134,159
91,039